Diabetic foot ulcers (DFUs) are open sores or ulcers on the feet that can occur in people with diabetes as a result of peripheral neuropathy, or damage to the nerves, and can severely compromise a patient’s quality of life.
This patient presented a highly challenging case as he had been suffering with an open diabetic foot ulcer with an exposed tendon for months after other advanced therapies failed. Upon being introduced to ACell’s wound management products, his physician applied Cytal™ Wound Matrix 1-Layer technology to the DFU. Four weeks later, the patient showed a healthy tissue bed over the closing wound. At six weeks after initial application, the patient achieved complete wound closure.
Diabetic ulcer with exposed tendon. Options include skin grafting.
Cytal™ Wound Matrix 1-Layer technology applied. Healthy tissue bed at 4 weeks.
Six weeks after initial application of Cytal.
This case contains the opinions of and personal techniques practiced by the treating physician. The techniques presented herein are for informational purposes only. The decision of which techniques to use in a particular clinical application lies with the physician based on patient profile, particular circumstances surrounding the procedure, and previous clinical experiences.
While these clinical experiences are valid, the results are not necessarily typical, indicative or representative of all procedures in which ACell’s devices are used. ACell’s product line of medical devices has been used successfully in many patients by physicians of varying specialties during a variety of medical procedures. Complications, reactions, and/or adverse events are possible with any medical intervention. It is not possible to predict or warrant specific results, nor is it possible to guarantee patient and/or clinician satisfaction.